<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Tianeptine - Complete Profile</title>
    <link rel="stylesheet" href="/Dyo-s-Dubious-Domain/style.css">
</head>

<body class="
  
  
  
  ">
    <header class="page-header">
  <div class="container">
    <div class="page-header__content">
      <div class="logo-container">
        <a href="/Dyo-s-Dubious-Domain/" class="site-title">Dyo's Dubious Domain</a>
      </div>
      
      <nav>
        <ul role="list" class="nav-list flex-group">
          <li>
            <a href="/Dyo-s-Dubious-Domain/">Home</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/dyos-domain/">Dyo's Domain</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/about/">About</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/profile/">My Profile</a>
          </li>
         
        </ul>
      </nav>
    </div>
    
    <!-- Search Bar - Now underneath header -->
    <div class="search-container">
      <input type="text" id="search-input" placeholder="Search substances..." class="search-input" />
      <div id="search-results" class="search-results" style="display: none;"></div>
    </div>
  </div>
</header>

    <main>
      
<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚Üí <a href="/dyos-domain/nootropics/">Nootropics</a> ‚Üí <span>Tianeptine</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>üß† Tianeptine</h1>
        <h2 class="chemical-name">Methyl 7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoate</h2>
        
        <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="Tianeptine" 
                data-category="Nootropics" 
                data-chemical="Methyl 7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoate">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Slang</h3>
          <div class="names-grid">
            <span class="alt-name brand">Stablon</span>
            <span class="alt-name brand">Coaxil</span>
            <span class="alt-name brand">Tatinol</span>
            <span class="alt-name street">Tia</span>
            <span class="alt-name street">Gas Station Heroin</span>
            <span class="alt-name street">ZaZa Red</span>
            <span class="alt-name street">ZaZa Silver</span>
            <span class="alt-name street">Tianna</span>
            <span class="alt-name chemical">Tianeptine Sodium</span>
            <span class="alt-name chemical">Tianeptine Sulfate</span>
            <span class="alt-name chemical">Tianeptine Free Acid</span>
            <span class="alt-name street">TD Red</span>
            <span class="alt-name street">Pegasus</span>
            <span class="alt-name street">Phenibut Plus</span>
            <span class="alt-name chemical">7-[(3-chlorodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid</span>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category nootropic">Nootropic</span>
          <span class="legal-status controlled">Controlled/Banned</span>
          <span class="duration short">2-4 hours</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="/assets/substances/tianeptine.jpg" alt="Tianeptine sodium powder and capsules" class="substance-photo">
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>Tricyclic structure with unique Œº-opioid receptor activity</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Pharmaceutical Forms</h4>
          <ul>
            <li><strong>Tianeptine Sodium:</strong> White crystalline powder, highly water-soluble</li>
            <li><strong>Tianeptine Sulfate:</strong> White powder, slower onset, longer duration</li>
            <li><strong>Tianeptine Free Acid:</strong> White powder, requires acid for absorption</li>
            <li><strong>Tablets:</strong> 12.5mg pharmaceutical tablets (Stablon/Coaxil)</li>
            <li><strong>Taste:</strong> Intensely bitter and metallic</li>
          </ul>
        </div>
        
        <div class="street-forms">
          <h4>Supplement Market Forms</h4>
          <ul>
            <li><strong>"Nootropic" capsules:</strong> Often underdosed or mislabeled</li>
            <li><strong>Bulk powder:</strong> Sold as research chemical or supplement</li>
            <li><strong>"Mood boosters":</strong> Mixed with other compounds in gas station products</li>
            <li><strong>ZaZa products:</strong> Branded tianeptine supplements with unknown dosing</li>
          </ul>
        </div>
        
        <div class="adulterants-warning">
          <h4>‚ö†Ô∏è Common Adulterants & Mixtures</h4>
          <p><strong>Phenibut combinations:</strong> Often mixed to enhance GABAergic effects</p>
          <p><strong>Caffeine additions:</strong> Masks sedating effects at higher doses</p>
          <p><strong>Unknown RC opioids:</strong> Some "tianeptine" products contain novel opioids</p>
          <p><strong>Underdosing scam:</strong> Many supplements contain far less than claimed</p>
          <p><strong>Contamination:</strong> Synthesis byproducts in underground production</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Dosage Guidelines</h3>
      <div class="dosage-warning">
        <h4>‚ö†Ô∏è CRITICAL DOSAGE WARNING</h4>
        <p><strong>Therapeutic window is EXTREMELY narrow.</strong> 12.5mg therapeutic doses vs. 25-50mg recreational doses lead to rapid physical dependence. <strong>Withdrawal begins within 3-6 hours and is SEVERE.</strong></p>
      </div>
      
      <div class="dosage-chart">
        <div class="dose-range threshold">
          <span class="range-label">Therapeutic (Sodium)</span>
          <span class="dose-amount">12.5mg 3x daily</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range light">
          <span class="range-label">Light Effects</span>
          <span class="dose-amount">25-50mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range common">
          <span class="range-label">Common (Danger Zone)</span>
          <span class="dose-amount">50-100mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range strong">
          <span class="range-label">Strong (High Dependence)</span>
          <span class="dose-amount">100-200mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range heavy">
          <span class="range-label">Heavy (Addiction Certain)</span>
          <span class="dose-amount">200mg+</span>
          <div class="dose-bar"></div>
        </div>
      </div>
      
      <div class="dosage-details">
        <h4>Dosage Considerations</h4>
        <ul>
          <li><strong>Salt differences:</strong> Sodium fast-acting, Sulfate longer duration</li>
          <li><strong>Dependence threshold:</strong> >25mg doses create physical dependence risk</li>
          <li><strong>Tolerance development:</strong> Extremely rapid, often within days</li>
          <li><strong>Withdrawal timing:</strong> Begins 3-6 hours after last dose</li>
          <li><strong>Redosing compulsion:</strong> Strong urge to redose due to short duration</li>
          <li><strong>Cross-tolerance:</strong> May develop tolerance to traditional opioids</li>
        </ul>
      </div>
      
      <p class="dosage-note"><strong>Medical Warning:</strong> Even "low" recreational doses (25-50mg) can lead to rapid physical dependence. Therapeutic doses should only be used under medical supervision with proper tapering protocols.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile</h3>
      
      <div class="effects-timeline">
        <h4>Timeline (Tianeptine Sodium)</h4>
        <div class="timeline-item">
          <span class="time">T+0:15-0:30</span>
          <span class="effect">Onset - mood lift, anxiety relief</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+0:30-2:00</span>
          <span class="effect">Peak - opioid-like warmth, euphoria</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+2:00-4:00</span>
          <span class="effect">Comedown - return to baseline</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+4:00-8:00</span>
          <span class="effect">Withdrawal begins - anxiety, depression, physical discomfort</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category positive">
          <h4>‚úÖ Reported Positive Effects</h4>
          <ul>
            <li>Rapid mood elevation and antidepressant effects</li>
            <li>Significant anxiety reduction</li>
            <li>Opioid-like warmth and euphoria</li>
            <li>Enhanced motivation and energy</li>
            <li>Improved focus and cognitive function</li>
            <li>Pain relief and muscle relaxation</li>
            <li>Social confidence boost</li>
          </ul>
        </div>
        
        <div class="effect-category negative">
          <h4>‚ùå Negative Effects</h4>
          <ul>
            <li>Rapid onset of physical dependence</li>
            <li>Severe withdrawal syndrome</li>
            <li>Compulsive redosing behavior</li>
            <li>Nausea and gastrointestinal issues</li>
            <li>Constipation and urinary retention</li>
            <li>Cognitive impairment at higher doses</li>
            <li>Sleep disruption and insomnia</li>
            <li>Respiratory depression (high doses)</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>Tianeptine is unique among antidepressants as it acts primarily as a Œº-opioid receptor agonist while also functioning as a serotonin reuptake enhancer (opposite of SSRIs). At therapeutic doses, it enhances serotonin reuptake and provides antidepressant effects. At higher doses, opioid receptor activation dominates, producing euphoria and physical dependence.</p>
        
        <h4>Detailed Receptor Pharmacology</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor">Œº-Opioid Receptor</span>
            <span class="activity">Full agonist</span>
            <span class="effect">Euphoria, analgesia, dependence</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">Œ¥-Opioid Receptor</span>
            <span class="activity">Partial agonist</span>
            <span class="effect">Mood enhancement, anxiolysis</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">SERT</span>
            <span class="activity">Reuptake enhancer</span>
            <span class="effect">Antidepressant action (low doses)</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">AMPA Receptors</span>
            <span class="activity">Positive modulation</span>
            <span class="effect">Neuroprotection, memory</span>
          </div>
          <div class="receptor-row">
            <span class="receptor">NMDA Receptors</span>
            <span class="activity">Antagonist properties</span>
            <span class="effect">Antidepressant augmentation</span>
          </div>
        </div>

        <h4>Metabolism & Pharmacokinetics</h4>
        <div class="metabolism-details">
          <p><strong>Primary metabolism:</strong> Hepatic metabolism via CYP enzymes to MC5 (active metabolite)</p>
          <p><strong>Half-life:</strong> 2.5-3 hours (sodium), 7-9 hours (sulfate)</p>
          <p><strong>Bioavailability:</strong> ~99% oral (sodium), ~60% (sulfate)</p>
          <p><strong>Peak plasma:</strong> 1 hour (sodium), 3-5 hours (sulfate)</p>
          <p><strong>Elimination:</strong> Primarily renal excretion</p>
          <p><strong>Active metabolites:</strong> MC5 has opioid activity but shorter duration</p>
        </div>

        <h4>Dependence & Withdrawal Mechanisms</h4>
        <div class="neurotoxicity-info">
          <p><strong>Œº-Opioid downregulation:</strong> Rapid receptor tolerance and dependence</p>
          <p><strong>Serotonin disruption:</strong> Enhanced reuptake leads to serotonin depletion</p>
          <p><strong>Withdrawal severity:</strong> Comparable to pharmaceutical opioids despite short duration</p>
          <p><strong>Rapid kindling:</strong> Withdrawal severity increases with each quit attempt</p>
          <p><strong>Cognitive effects:</strong> Memory and attention deficits during withdrawal</p>
        </div>

        <h4>Unique Pharmacological Properties</h4>
        <ul>
          <li><strong>Tricyclic structure:</strong> Similar to traditional antidepressants but unique mechanism</li>
          <li><strong>Dose-dependent effects:</strong> Antidepressant at low doses, opioid at higher doses</li>
          <li><strong>Neuroplasticity:</strong> Enhances BDNF and promotes synaptic plasticity</li>
          <li><strong>Stress resilience:</strong> Prevents stress-induced dendritic atrophy</li>
          <li><strong>Rapid onset:</strong> Faster acting than traditional antidepressants</li>
          <li><strong>Abuse liability:</strong> High potential for misuse due to opioid effects</li>
        </ul>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†Ô∏è Safety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® Critical Warnings</h4>
          <ul>
            <li><strong>Rapid dependence:</strong> Physical addiction can develop within days of use</li>
            <li><strong>Severe withdrawal:</strong> Intense psychological and physical withdrawal syndrome</li>
            <li><strong>Short duration trap:</strong> 2-4 hour effects lead to compulsive redosing</li>
            <li><strong>Respiratory depression:</strong> High doses can cause breathing difficulties</li>
            <li><strong>No safe recreational dose:</strong> Any misuse carries addiction risk</li>
            <li><strong>Tolerance permanence:</strong> Tolerance may persist long after discontinuation</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°Ô∏è Harm Reduction (If Use Cannot Be Avoided)</h4>
          <ul>
            <li><strong>Never exceed 12.5mg:</strong> Therapeutic doses only, under medical supervision</li>
            <li><strong>Set strict limits:</strong> Pre-plan dosing schedule and stick to it</li>
            <li><strong>Avoid daily use:</strong> No more than 2-3 times per week maximum</li>
            <li><strong>Taper carefully:</strong> Never stop abruptly, medical supervision required</li>
            <li><strong>Monitor for dependence:</strong> Watch for withdrawal symptoms between doses</li>
            <li><strong>Support system:</strong> Have medical and psychological support available</li>
            <li><strong>Alternative treatments:</strong> Explore safer antidepressant options first</li>
          </ul>
        </div>
      </div>

      <div class="contraindications">
        <h4>üö´ Absolute Contraindications</h4>
        <p><strong>Never use if you have:</strong> History of substance abuse, respiratory conditions, liver disease, kidney problems, or are taking MAOIs, opioids, or CNS depressants. Not suitable for recreational use under any circumstances.</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏è Drug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üî¥ Deadly Combinations</h4>
          <ul>
            <li><strong>Opioids:</strong> Synergistic respiratory depression, fatal overdose risk</li>
            <li><strong>Benzodiazepines:</strong> Combined CNS depression can cause death</li>
            <li><strong>Alcohol:</strong> Dramatically increased sedation and respiratory depression</li>
            <li><strong>MAOIs:</strong> Potentially fatal serotonin syndrome</li>
            <li><strong>Other CNS depressants:</strong> Cumulative respiratory depression</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üü° High Risk</h4>
          <ul>
            <li><strong>SSRIs/SNRIs:</strong> Conflicting serotonin effects, unpredictable interactions</li>
            <li><strong>Tramadol:</strong> Combined opioid and serotonin effects</li>
            <li><strong>Gabapentinoids:</strong> Enhanced sedation and respiratory depression</li>
            <li><strong>Antihistamines:</strong> Increased sedation and confusion</li>
          </ul>
        </div>
        
        <div class="interaction caution">
          <h4>üü† Use Extreme Caution</h4>
          <ul>
            <li><strong>Any antidepressants:</strong> Conflicting mechanisms of action</li>
            <li><strong>Stimulants:</strong> May mask tianeptine's sedating effects</li>
            <li><strong>Blood thinners:</strong> Potential interaction with metabolism</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏è Legal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <div class="jurisdiction">
            <h4>üá´üá∑ France</h4>
            <p>Prescription medication - Stablon/Coaxil for depression treatment</p>
          </div>
          <div class="jurisdiction">
            <h4>üá∫üá∏ United States</h4>
            <p>Controlled in multiple states, banned in several others, DEA monitoring</p>
          </div>
          <div class="jurisdiction">
            <h4>üá¨üáß United Kingdom</h4>
            <p>Controlled under Psychoactive Substances Act, prescription-only medicine</p>
          </div>
          <div class="jurisdiction">
            <h4>üåç International</h4>
            <p>Increasingly controlled worldwide due to abuse potential</p>
          </div>
        </div>
        
        <div class="therapeutic-status">
          <h4>üè• Medical Status</h4>
          <p>Tianeptine remains a legitimate antidepressant medication in some countries, but its abuse potential has led to increasing restrictions. Many jurisdictions are moving to control or ban it due to its opioid-like effects and dependence risk.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History & Culture</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">1960s</span>
          <p>First synthesized by French researchers as a potential antidepressant</p>
        </div>
        <div class="history-event">
          <span class="year">1989</span>
          <p>Approved in France as Stablon for depression treatment</p>
        </div>
        <div class="history-event">
          <span class="year">2000s</span>
          <p>Marketed internationally, opioid receptor activity discovered</p>
        </div>
        <div class="history-event">
          <span class="year">2010s</span>
          <p>Emerges in nootropic/supplement markets online</p>
        </div>
        <div class="history-event">
          <span class="year">2014</span>
          <p>First reports of tianeptine abuse and dependence in medical literature</p>
        </div>
        <div class="history-event">
          <span class="year">2018</span>
          <p>"Gas station heroin" epidemic begins in southeastern US</p>
        </div>
        <div class="history-event">
          <span class="year">2020-present</span>
          <p>Increasing state-level bans and federal scheduling consideration</p>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>Cultural Impact</h4>
        <p>Tianeptine represents the dangerous intersection of legitimate medicine and substance abuse. Originally developed as a safer antidepressant, it evolved into a "legal high" sold in gas stations and supplement stores, leading to a hidden opioid crisis particularly affecting rural and low-income communities.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Current Research</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Addiction Treatment</h4>
          <p>Research into tianeptine addiction treatment protocols, including buprenorphine and suboxone for withdrawal management and maintenance therapy.</p>
        </div>
        
        <div class="research-item">
          <h4>Abuse Potential Studies</h4>
          <p>Investigation into tianeptine's abuse liability and comparison with traditional opioids to inform regulatory decisions and clinical guidelines.</p>
        </div>
        
        <div class="research-item">
          <h4>Mechanism Research</h4>
          <p>Studies examining tianeptine's unique dual mechanism and potential for developing safer antidepressants without opioid activity.</p>
        </div>
        
        <div class="research-item">
          <h4>Withdrawal Management</h4>
          <p>Clinical trials investigating optimal protocols for tianeptine withdrawal and dependence treatment, including both pharmacological and behavioral approaches.</p>
        </div>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Additional Resources</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Medical Resources</h4>
        <ul>
          <li><a href="https://www.poison.org/">Poison Control</a> - Emergency guidance</li>
          <li><a href="https://www.samhsa.gov/">SAMHSA</a> - Addiction treatment locator</li>
          <li><strong>Medical supervision required</strong> for safe discontinuation</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Support Resources</h4>
        <ul>
          <li><a href="https://www.reddit.com/r/QuittingTianeptine/">r/QuittingTianeptine</a> - Recovery community</li>
          <li><a href="https://www.na.org/">Narcotics Anonymous</a> - 12-step support</li>
          <li><strong>Professional counseling</strong> recommended for recovery</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Educational Resources</h4>
        <ul>
          <li><a href="https://www.erowid.org/">Erowid</a> - Experience reports and information</li>
          <li><a href="https://psychonautwiki.org/">PsychonautWiki</a> - Comprehensive drug information</li>
          <li><strong>Medical literature</strong> for healthcare providers</li>
        </ul>
      </div>
    </div>
  </div>

</div>
    </main>
     <div class="footer-divider"></div>
<footer class="site-footer">
  
</footer>




<footer class="site-footer">
  
  </svg>
    <img src="/assets/logo.svg" alt="My Logo" class="logo">
     <p>¬© 2025 Uwaniumnya. Highly Illegal.</p>
  </footer>

  

    <!-- Search Scripts -->
    <script src="/Dyo-s-Dubious-Domain/js/lunr.min.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/search.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/substance-integration.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/profile.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/friends.js"></script>
</body>
</html>